Uncategorised Archives - Page 2 of 2 - Journal for Clinical Studies

Current Edition

Uncategorised

Novartis presents first-of-its-kind algorithm-based tool to help MS patients and physicians

Novartis today announced results from a validation study of the innovative, algorithm-based digital solution MS Progression Discussion Tool, or MSProDiscussTM. The t...

9 May 2019 Uncategorised

Continue Reading →

Uncategorised

FDA approves new treatments for heart disease caused by a serious rare disease, transthyretin mediated amyloidosis

On May 3, the U.S. Food and Drug Administration approved Vyndaqel (tafamidis meglumine) and Vyndamax (tafamidis) capsules for the treatment of the heart disease (car...

9 May 2019 Uncategorised

Continue Reading →

Uncategorised

Szpital Specjalistyczny w Brzozowie, Poland, joins the global hospital network on Clinerion?s Patient Network Explorer platform.

Szpital Specjalistyczny w Brzozowie, (the Specialist Hospital in Brzoz?w), Poland, specializes in oncology, hematology and cardiology. The hospital has 485 beds and ...

13 March 2019 Uncategorised

Continue Reading →

Uncategorised

Hello world!

Welcome to WordPress. This is your first post. Edit or delete it, then start writing!

29 January 2019 Uncategorised

Continue Reading →

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Rare Disease Ebook

Vaccine – Shorten Start-Up Timelines in Vaccine Trials

Current Edition

Novartis presents first-of-its-kind algorithm-based tool to help MS patients and physicians

FDA approves new treatments for heart disease caused by a serious rare disease, transthyretin mediated amyloidosis

Szpital Specjalistyczny w Brzozowie, Poland, joins the global hospital network on Clinerion?s Patient Network Explorer platform.

Hello world!

Journal for Clinical Studies